Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Study of Continuous OSI-906 Dosing [Phase 1]
A Phase 1 study evaluating continuous dosing of OSI-906 in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®) [Phase 1]
A Phase 1 dose-escalation study evaluated the combination of OSI-906 and Erlotinib (Tarceva) in patients with advanced solid tumors; the tri…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System [Phase 1, Phase 2]
Takeda's TAK-981 was studied in Phase 1/2 trials for advanced solid tumors and hematologic malignancies, but the study was terminated with r…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Varian ProBeam Proton Therapy System China Clinical Trial (Hefei) [NA]
The Varian ProBeam Proton Therapy System trial conducted in Hefei, China has completed, with results posted on 2024-11-15.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer. [Phase 1]
Phase 1 study evaluating safety and early therapeutic activity of ANV419 in adults with advanced solid tumors, including lung cancer, has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY [Phase 1]
The PREV-NOSE Phase 1 trial evaluating Nozin to prevent respiratory viral infections in patients undergoing stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body [Phase 1]
Phase 1 pharmacokinetic study of a single oral dose of 14C-OSI-906 in patients with solid tumors, examining absorption, metabolism, and elim…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 pharmacokinetic study evaluating absorption, metabolism and excretion of [14C] ASP2215 (gilteritinib) in patients with advanced soli…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 [Phase 1]
Phase 1 study of MT-6402 in PD-L1-expressing advanced solid tumors, including non-small cell lung cancer and squamous cell carcinoma of the …
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects [Phase 1]
Phase 1 safety and pharmacokinetic data for RRx-001 in cancer patients; the trial (solid tumors and lymphomas) has completed and results wer…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of ASP1948 in Japanese patients with locally advanced or metastatic solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma [Phase 1]
Phase 1 dose-escalation and expansion study of ASP4132 in patients with lymphoma and solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid Tumors [Phase 1]
An open-label Phase I study evaluating ASP5878, an oral FGFR1-4 inhibitor, in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: BT1718 in Patients with Advanced Solid Tumours. [Phase 1, Phase 2]
This clinical trial update reports on BT1718 in patients with advanced solid tumors in Phase 1/2, with the study status completed. Condition…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma [Phase 1, Phase 2]
Regeneron’s cemiplimab (REGN2810) was studied in pediatric patients with relapsed/refractory solid tumors and CNS tumors, including a safety…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002) [Phase 1, Phase 2]
A Phase 1/2 study of MK-1088, both as monotherapy and in combination with pembrolizumab, in adults with advanced solid tumors was terminated…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib [Phase 1]
Phase 1 trial update of a combination of PI3 kinase inhibitors and Palbociclib (PIPA) for advanced solid tumors and breast cancer has comple…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly [Phase 1]
Phase I trial evaluating ONX-0801 given weekly or every other week in patients with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China [Phase 1, Phase 2]
First-in-human study of JAB-3068, an SHP2 inhibitor, in adults with advanced solid tumors in China, including non-small cell lung cancer, he…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NHL) [Phase 1]
A Phase 1 study of CC-122 in Japanese patients with advanced solid tumors and Non-Hodgkin lymphoma was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer [Phase 1, Phase 2]
IMP4297 combined with temozolomide was studied in patients with advanced solid tumors and small cell lung cancer in Phase 1/Phase 2 trials, …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive) [Phase 1]
A Phase 1 dose-escalation study of BI 3011441 in Japanese patients with NRAS- or KRAS-mutant advanced solid tumors has completed and posted …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors [Phase 1]
Phase 1 study shows safety, pharmacokinetics and preliminary anti-tumor activity of RP12146 in patients with solid tumors, including extensi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors [Phase 1]
Phase 1 first-in-human study of oral TP-1287 in patients with advanced solid tumors, including specific sarcoma subtypes, has been terminate…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI [Phase 1]
Phase 1 pharmacokinetic comparison of TAS-102 tablets versus an oral solution containing equivalent amounts of trifluridine and tipiracil; s…